Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#2213 most reported symptom for this vaccine
Coronary artery thrombosis has been reported 3 times in association with HPV (Gardasil) vaccination in VAERS. This represents 0.0% of all 44,434 reports for this vaccine.
Among these reports, 3 mentioned death (100.00%) and 0 involved hospitalization (0.0%).
Coronary artery thrombosis is the #2213 most frequently reported symptom for HPV (Gardasil) out of 2579 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 3 reports of Coronary artery thrombosis after HPV (Gardasil) vaccination may seem alarming, but context is critical.
The 100.00% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.